Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kontrol Technologies Corp N.KNR

Alternate Symbol(s):  KNRLF

Kontrol Technologies Corp. is a provider of energy management, continuous air quality and emission solutions to commercial and industrial consumers. It delivers building intelligence through the Internet of things (IoT), software and cloud technology as well as project integration. Its smart technology is deployed to customers through a cloud-based interface accessible on desktops and mobile... see more

NEO:KNR - Post Discussion

Kontrol Technologies Corp > News out from Japan - 03/08/2022
View:
Post by topseeker on Mar 08, 2022 11:07am

News out from Japan - 03/08/2022

Hi All Longs,

 Got to seriously love this news.

 I do. 

 Enjoy the read: 

 

Kontrol's BioCloud identifies influenza virus

 

2022-03-08 10:34 ET - News Release

 

Mr. Paul Ghezzi reports

KONTROL BIOCLOUD TECHNOLOGY IDENTIFIES INFLUENZA VIRUS IN TESTING

Kontrol Technologies Corp. has completed initial testing of the BioCloud technology in Japan and has delivered a positive detection of the influenza virus. The initial testing indicates the application of the BioCloud technology for influenza virus.

"The BioCloud technology innovation is based on taking a manual laboratory process and automating that process in real time, with the goal of monitoring ambient air for early viral detection," says Gary Saunders, president of Kontrol BioCloud. "Since the inception of our technology development we have indicated our intention to be able to detect multiple virus and pathogens as part of overall area safety. We are pleased with the initial positive testing with aerosolized influenza virus."

Initial testing

Further to the press release dated Jan. 14, 2022 (Kontrol Technologies expands BioCloud Technology into Japan), and working with its local partner, testing was provided through a laboratory in Japan and the initial testing was focused on the ability of Kontrol BioCloud to capture aerosolized influenza virus in its proprietary collection chamber. Based on initial testing the BioCloud technology was able to successfully capture the virus.

The testing summary of initial testing findings are provided on pages 15 to 17 of the BioCloud testing document.

"With a growing movement to monitor air quality in buildings with early viral detection systems, BioCloud continues to be well positioned to offer solutions that seek to create safer spaces across the global economy," says Paul Ghezzi, chief executive officer of Kontrol Technologies.

The company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 coronavirus).

About Kontrol Technologies Corp.

Kontrol Technologies, a Canadian public company, is a leader in smart buildings and cities through Internet of Things, cloud and software-as-a-service technology. Kontrol provides solutions and services to its customers to improve energy management, monitor continuous emissions and accelerate the sustainability of all buildings.


 Best of wishes to All longs,

 Sincerely,

 Topseeker

Comment by Edcando on Mar 08, 2022 11:28am
Wait what?! This can't be?! You mean the comp y is working hard behind the scenes continuing to increase shareholder value in a rel way without holding yanks hand every day? Say it ain't so Nava joe. 
Comment by topseeker on Mar 08, 2022 4:21pm
 As we move forward more viral pathogens will be tested for BioCloud detection. This was a critical pathogen tested as the Spanish Flu killed 50+M globally in under 2 years.  It was estimated that 500M people ( 1/3 world population) became infected with this flu.  In the US alone, the Spanish Flu was the deadliest disease in American history.  Is detection becoming more ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities